NCAM1 and neuroblastic tumor: Thus, among neuroblastic tumors, i) CD90, GD2, CD9, and CD56 were the most discriminative between NBL and GNB, whereas ii) CD271, EpCAM, CD9, and CD81 discriminated NBL from PHEO.